Journal: NPJ Precision Oncology
Article Title: Multi-cancer detection of circulating tumor cells by targeting oncofetal chondroitin sulfate
doi: 10.1038/s41698-025-00936-3
Figure Lengend Snippet: a The number of ofCS+ CTCs detected with rVAR2:dextran in 4 mL of blood in patients with epithelial cancer (n = 25) or mesenchymal cancer (n = 3) and in healthy controls (n = 13). The samples were stained with PE-labelled rVAR2:dextran and APC-conjugated antibodies targeting CD45, CD66b and CD16. Cell nuclei were stained with DAPI. b Representative immunofluorescence images of ofCS+ CTCs from six different cancer patients. The CTCs were stained as described in ( a ). A CTC was defined as ofCS(+), CD45(−), CD66b (−), CD16(−) and DAPI(+).
Article Snippet: Subsequently, the samples were stained with a cocktail of PE-conjugated dextran complexed with rVAR2 (4 nM) in combination with APC-labelled antibodies targeting CD45 (1:20, Thermo Fischer, 17-0459-42, clone: HI30), CD16 (1:40, Thermo Fischer, MHCD1605, clone: 3G8), and CD66b (1:20, Miltenyi Biotec, 130-117-692, clone: REA306) in DPBS containing 2% FBS with an adjusted NaCl concentration of 300 mM (final concentration).
Techniques: Staining, Immunofluorescence